Can’t see the audio participant? Click on right here to pay attention on SoundCloud. You may also pay attention on Spotify, Apple Podcasts, Stitcher, Pocket Casts or wherever you hearken to podcasts.
Democrats in Congress and the White Home are feverishly negotiating to go as a lot of President Joe Biden’s home agenda as they will agree on, at the same time as Republicans who oppose a lot of the elevated spending threaten to close down the federal government and default on the nation’s debt.
In the meantime, confusion over so-called booster photographs for covid-19 continues, and advocates on each side of the abortion debate attempt to take a look at Texas’ novel abortion legislation that the Supreme Courtroom allowed to take impact Sept. 1.
This week’s panelists are Julie Rovner of KHN, Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Name and Sarah Karlin-Smith of the Pink Sheet.
Among the many takeaways from this week’s episode:
- As Democratic lawmakers wrestle with efforts to please completely different factions of the get together on the enormous “human infrastructure” invoice, the stakes are huge. The invoice encompasses dozens of large coverage adjustments, and every one alone may very well be the topic of main laws that in previous years would have taken months to barter. Failure to succeed in sufficient settlement to get the invoice handed may trigger extreme ramifications for the get together within the subsequent spherical of elections and for the Biden administration.
- Among the many key disagreements over well being coverage in that laws is what Congress can do to carry down prescription drug costs. Negotiations are ongoing, however Sen. Ron Wyden (D-Ore.), who as head of the Finance Committee would have a robust hand within the closing deal, is holding his playing cards near his chest on what he’ll assist.
- Regardless of the rhetoric across the drug-pricing subject, it seems the factions of the Democratic Celebration are usually not against all curbs. The dispute is over how one can limit worth will increase and by how a lot.
- The drug business is anticipating to take successful within the laws, however it’s utilizing a broad promoting marketing campaign to emphasize its want for funding to make medical improvements. Nonetheless, the general public appears inclined to need each: decrease costs and higher drug choices. Plus, shopper advocates observe that not all incentives within the present system are geared towards innovation and infrequently reward solely slight enhancements in medicine.
- The present confusion about when and who ought to get a further covid shot is complicated People. Officers on the Facilities for Illness Management and Prevention appear to need a extra cohesive technique that doesn’t single out particular vaccines, however the push by the White Home earlier this month added to the strain to get these photographs shifting.
- The U.S. promised extra vaccine doses this week for underdeveloped international locations since one of many greatest obstacles to getting folks vaccinated in creating nations is a scarcity of provide. However logistical issues loom giant.
Additionally this week, Rovner interviews Dr. Scott Gottlieb, former commissioner of the Meals and Drug Administration. He has a brand new e book, titled “Uncontrolled Unfold: Why COVID-19 Crushed Us and How We Can Defeat the Subsequent Pandemic.”
Plus, for further credit score, the panelists suggest their favourite well being coverage tales of the week they suppose you need to learn too:
Julie Rovner: The New York Instances’ “Their Child Died within the Hospital. Then Got here the $257,000 Invoice,” by Sarah Kliff
Joanne Kenen: The New Yorker’s “The Battle to Outline Lengthy Covid,” by Dhruv Khullar
Mary Ellen McIntire: KHN’s “Will ‘Dr. Disinformation’ Ever Face the Music?” by Victoria Knight
Sarah Karlin-Smith: The Washington Put up’s “The World’s Tallest Populace Is Shrinking, and Scientists Wish to Know Why,” by Rachel Pannett
To listen to all our podcasts, click on right here.
And subscribe to KHN’s What the Well being? on Spotify, Apple Podcasts, Stitcher, Pocket Casts or wherever you hearken to podcasts.
We encourage organizations to republish our content material, freed from cost. Right here’s what we ask:
You will need to credit score us as the unique writer, with a hyperlink to our khn.org web site. If doable, please embody the unique creator(s) and “Kaiser Well being Information” within the byline. Please protect the hyperlinks within the story.
It’s vital to notice, not the whole lot on khn.org is accessible for republishing. If a narrative is labeled “All Rights Reserved,” we can not grant permission to republish that merchandise.
Have questions? Tell us at KHNHelp@kff.org